Literature DB >> 25696296

The value of (NT-pro) BNP in the diagnosis, prognosis and treatment of congestive heart failure.

R R J van Kimmenade, J A Bakker, H J G M Crijns, M P van Dieijen-Visser, Y M Pinto.   

Abstract

Congestive heart failure constitutes one of the major causes of morbidity and mortality in Western countries. However, it is often misdiagnosed and the validity of the diagnosis is often difficult to establish. The clinical signs are not very sensitive and symptoms are nonspecific. Secretion of natriuretic peptides is increased in situations of cardiac overload. Testing the levels of these peptides, especially BNP and NT-proBNP, appears to offer a significant advance in the diagnosis and treatment of heart failure. In this article we would like to discuss the value of natriuretic peptides in congestive heart failure and give a short review of the literature.

Entities:  

Keywords:  congestive heart failure; natriuretic peptides; review

Year:  2004        PMID： 25696296      PMCID： PMC2497073     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  14 in total

Review 1.  Natriuretic peptides.

Authors:  E R Levin; D G Gardner; W K Samson
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

2.  Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure.

Authors:  Dalane W Kitzman; William C Little; Peter H Brubaker; Roger T Anderson; W Gregory Hundley; Christian T Marburger; Bridget Brosnihan; Timothy M Morgan; Kathryn P Stewart
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

3.  B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea.

Authors:  Alex Harrison; L Katherine Morrison; Padma Krishnaswamy; Radmila Kazanegra; Paul Clopton; Quyen Dao; Patricia Hlavin; Alan S Maisel
Journal:  Ann Emerg Med       Date:  2002-02       Impact factor: 5.721

4.  Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.

Authors:  A Clerico; G Iervasi; M G Del Chicca; M Emdin; S Maffei; M Nannipieri; L Sabatino; F Forini; C Manfredi; L Donato
Journal:  J Endocrinol Invest       Date:  1998-03       Impact factor: 4.256

5.  Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

Authors:  K Yamamoto; J C Burnett; M Jougasaki; R A Nishimura; K R Bailey; Y Saito; K Nakao; M M Redfield
Journal:  Hypertension       Date:  1996-12       Impact factor: 10.190

6.  A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps).

Authors:  H Schweitz; P Vigne; D Moinier; C Frelin; M Lazdunski
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 7.  B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

Authors:  Peter A McCullough; Torbjørn Omland; Alan S Maisel
Journal:  Rev Cardiovasc Med       Date:  2003       Impact factor: 2.930

8.  Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.

Authors:  M R Cowie; A D Struthers; D A Wood; A J Coats; S G Thompson; P A Poole-Wilson; G C Sutton
Journal:  Lancet       Date:  1997-11-08       Impact factor: 79.321

9.  Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.

Authors:  M Yoshimura; H Yasue; E Morita; N Sakaino; M Jougasaki; M Kurose; M Mukoyama; Y Saito; K Nakao; H Imura
Journal:  Circulation       Date:  1991-10       Impact factor: 29.690

10.  Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure.

Authors:  Serge Masson; Tarcisio Vago; Gabriella Baldi; Monica Salio; Noeleen De Angelis; Enrico Nicolis; Aldo P Maggioni; Roberto Latini; Guido Norbiato; Maurizio Bevilacqua
Journal:  Clin Chem Lab Med       Date:  2002-08       Impact factor: 3.694
View more
  2 in total

1.  The Role of NT-proBNP in the Diagnosis of Ventricular Arrhythmias in Patients with Systemic Sclerosis.

Authors:  Lucian Muresan; Ana Petcu; Crina Muresan; Mirela Rinzis; Gabriel Gusetu; Dana Pop; Dumitru Zdrenghea; Simona Rednic
Journal:  Iran J Public Health       Date:  2017-07       Impact factor: 1.429

2.  Effects of High-Dose Rosuvastatin on Ventricular Remodelling and Cardiac Function in ST-Segment Elevation Myocardial Infarction.

Authors:  Rong Luo; Xiaochen Sun; Feiyan Shen; Bin Hong; Zilong Wang
Journal:  Drug Des Devel Ther       Date:  2020-09-23       Impact factor: 4.162
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.